Management of arrythmias.
The management of arrhythmias in elderly patients with congestive heart failure, including atrial fibrillation, ventricular tachyarrhythmias, and bradyarrhythmias, is described. Patients with atrial fibrillation can be treated with rate control anticoagulation for stroke prevention or by attempt at cardioversion and maintenance of sinus rhythm. Elderly patients remaining in atrial fibrillation benefit from anticoagulation provided that no contraindication exists. In patients surviving malignant ventricular arrhythmias, defibrillator implantation is beneficial in elderly patients with heart failure. Prognosis and treatment of nonsustained arrhythmias depends on the presence of underlying cardiac abnormalities. In the healthy elderly population, treatment is not indicated. In patients with coronary artery disease, decreased ejection fraction, and nonsustained ventricular tachycardia, electrophysiology can further stratify risk, and defibrillator implantation can improve survival if arrhythmias are induced. This benefit is as great in elderly patients as in younger patients. Symptomatic bradycardias are increasingly common with advancing age. Symptoms are improved with pacing, with maximum benefit from physiologic rather than ventricular pacing. Although the elderly population poses a unique challenge when faced with arrhythmias, an active approach not only saves lives but also reduces morbidity.
Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
R
R
Lampert
M D
MD
Ezekowitz
D000367:Age Factors; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*; D001919:Bradycardia / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*; D017147:Defibrillators, Implantable; D004554:Electric Countershock; D006333:Heart Failure / Q000150:complications*; D006801:Humans; D015994:Incidence; D015995:Prevalence; D011379:Prognosis; D012307:Risk Factors; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D017180:Tachycardia, Ventricular / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants